Can primaquine therapy for vivax malaria be improved?
The incidence and range of endemic malaria caused by Plasmodium vivax has expanded during the past 30 years. This parasite forms hypnozoites in the liver, creating a persistent reservoir of infection. Primaquine (PQ), introduced 50 years ago, is the only drug available to eliminate hypnozoites. Howe...
Auteurs principaux: | Baird, J, Rieckmann, K |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2003
|
Documents similaires
-
Therapeutic principles of primaquine against relapse of Plasmodium vivax malaria
par: Baird, J
Publié: (2018) -
Primaquine as anti-relapse therapy for Plasmodium vivax
par: Baird, J
Publié: (1998) -
Primaquine therapy for malaria.
par: Baird, J, et autres
Publié: (2004) -
High-dose primaquine regimens against relapse of Plasmodium vivax malaria.
par: Krudsood, S, et autres
Publié: (2008) -
Treatment of primaquine-resistant Plasmodium vivax malaria.
par: Luzzi, G, et autres
Publié: (1992)